Results 201 to 210 of about 48,469 (263)

Reproductive outcomes in women with Hodgkin's lymphoma in a Danish fertility preservation cohort

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1587-1596, August 2026.
The risk of premature ovarian insufficiency increases with the intensity of alkylating chemotherapy. In general, fertility outcomes were favorable, but chances of live birth decreased with increased intensity of alkylating chemotherapy. Ovarian tissue transplantation enabled natural conception in women with premature ovarian insufficiency, supporting ...
Lotte Berdiin Colmorn   +4 more
wiley   +1 more source

A Rare Case of Primary Thyroid Lymphoma. [PDF]

open access: yesCureus
Zitser D   +4 more
europepmc   +1 more source

Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular Insights

open access: yesCancer Science, Volume 117, Issue 8, Page 2029-2039, August 2026.
Schematic overview of progression from differentiated thyroid carcinoma (DTC) to anaplastic thyroid carcinoma (ATC). ATC primarily develops via two pathways: the BRAF p.V600E‐mutated papillary thyroid carcinoma (PTC) pathway and the RAS‐mutated pathway. The origin and progression of BRAF/RAS‐wildtype ATC remain unclear.
Toru Odate, Tetsuo Kondo
wiley   +1 more source

IgG4‐Related Disease Overlapping With Anti‐Acetylcholine Receptor Antibody–Positive Myasthenia Gravis

open access: yesClinical and Experimental Neuroimmunology, Volume 17, Issue 3, August 2026.
ABSTRACT Background IgG4‐related disease (IgG4‐RD) is a systemic, immune‐mediated, fibroinflammatory disorder with multiorgan involvement and variable clinical presentation, often creating diagnostic difficulty. Myasthenia gravis (MG) is an antibody‐mediated autoimmune disorder of the neuromuscular junction, most commonly associated with anti ...
Yumiko Yoshida   +4 more
wiley   +1 more source

Odronextamab in people with relapsed or refractory follicular lymphoma: plain language summary of the ELM-2 study. [PDF]

open access: yesFuture Oncol
Villasboas JC   +10 more
europepmc   +1 more source

Population Pharmacokinetics of Rituximab in Treatment‐Naïve Chinese Patients With Diffuse Large B‐cell Lymphoma During Induction Therapy: Clinical Implications

open access: yesClinical and Translational Science, Volume 19, Issue 8, August 2026.
A schematic summary of the population pharmacokinetic model of rituximab in treatment‐naïve Chinese DLBCL patients during induction therapy, along with key clinical implications. ABSTRACT This study aimed to establish and validate a population pharmacokinetic model for rituximab during induction therapy in treatment‐naive patients with diffuse large B ...
Wan‐Yi Zhou   +5 more
wiley   +1 more source

S3 guideline diagnostics and therapy in alopecia areata – Part 2: Therapy, psychosocial and cosmetic support

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 8, Page e1155-e1177, August 2026.
Summary This second part of the S3 guideline on the diagnosis and treatment of alopecia areata (AA), presents key recommendations on topical and systemic therapy, quality of life and support services. The first part of the guideline, published separately, covers the definition and content of epidemiology and diagnosis as well as comorbidities, risk and
Ulrike Blume‐Peytavi   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy